RFP - 2-PAM Autoinjectors for Project Bioshield (PBS)
Award
$340,910,795
Recipient
KALEO, INC.
Sep 28, 2026
Key details
Notice type
Award Notice
NAICS code
541714
PSC / classification
AB12
Set-aside
No Set aside used
Place of performance
Washington, District of Columbia
Response deadline
—
Solicitation summary
This acquisition will allow BARDA to invest Project Bioshield funds for late-stage clinical development, regulatory approval for 2-PAM autoinjectors (as a drug/device combination product) to treat organophosphate (OP) poisoning, including nerve agents, in adult and pediatric populations, and procurement of 2-PAM autoinjectors for the SNS/CHEMPACK Program.
Read the full solicitation
Start free to unlock the complete notice, the contracting officer’s contact details, and every solicitation document.
Contracting officers
Erin Greninger, Contracting Officer
Activity in our index
7 opportunities · avg award $340.9M (1) · last active Sep 30, 2026.
Greg Smith
Activity in our index
6 opportunities · avg award $340.9M (1) · last active Sep 30, 2026.
Contact the contracting officer
Draft an outreach email with AI
A tailored, professional email to the contracting officer about this solicitation — written in seconds, grounded in this notice.
Free with an account · included with a WinAContract account. AI-written, grounded in this notice — review before sending.
Market intelligence
Send it to GovCon — docs + AI brief, automatically.
We pull the solicitation files and summarize what you need to know.